PETERS KEVIN G. 4
4 · Aerpio Pharmaceuticals, Inc. · Filed May 16, 2019
Insider Transaction Report
Form 4
PETERS KEVIN G.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-05-14+63,250→ 63,250 totalExercise: $1.04Exp: 2029-05-14→ Common Stock (63,250 underlying) - Award
Stock Option (Right to Buy)
2019-05-14+266,550→ 266,550 totalExercise: $1.04Exp: 2029-05-14→ Common Stock (266,550 underlying)
Footnotes (2)
- [F1]Options exercisable as to 1/4th on the first anniversary of the grant date and an additional 1/48th monthly thereafter until the fourth anniversary of the grant date.
- [F2]50% of the shares shall vest on June 30, 2020 and the remaining 50% shall vest on June 30, 2021.